A Clinical Study of Calderasib (MK-1084) in Participants With Renal Impairment (MK-1084-010)

Clinical trial NCT06814119 · COMPLETED

Trial details

NCT number: NCT06814119
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Renal Impairment

Start date: 2025-04-07
Primary completion: 2026-01-23
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.